By Dennis Shasha
Communications of the ACM,
January 2019,
Vol. 62 No. 1, Pages 120-ff
10.1145/3293576
Comments
Consumers and pharmaceutical companies have been known to disagree over drug prices but have at least one interest in common: Neither wants the consumer to consume counterfeit drugs. The drug companies do not want to lose the sales, and consumers may have a critical need for the drug they paid for.
Counterfeiters have other ideas, however, so produce and sell packages full of fakes (usually simple sugar pills) in a $100 billion-per-year worldwide business. The drug companies have fought such fakery by incorporating special packaging (holograms, unique numbers, sometimes even electronic tags) on the drug containers. With so much money to gain by selling sugar pills for high prices, however, the counterfeiters have managed to copy the packaging very expertly.
No entries found
Log in to Read the Full Article
Need Access?
Please select one of the options below for access to premium content and features.
Create a Web Account
If you are already an ACM member, Communications subscriber, or Digital Library subscriber, please set up a web account to access premium content on this site.
Join the ACM
Become a member to take full advantage of ACM's outstanding computing information resources, networking opportunities, and other benefits.
Subscribe to Communications of the ACM Magazine
Get full access to 50+ years of CACM content and receive the print version of the magazine monthly.
Purchase the Article
Non-members can purchase this article or a copy of the magazine in which it appears.